These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7719904)

  • 21. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response to inactivated influenza vaccines of various antigenic concentrations.
    Sullivan KM; Monto AS; Foster DA
    J Infect Dis; 1990 Feb; 161(2):333-5. PubMed ID: 2299213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.
    Brokstad KA; Cox RJ; Major D; Wood JM; Haaheim LR
    Vaccine; 1995 Nov; 13(16):1522-8. PubMed ID: 8578836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.
    Bacon A; Makin J; Sizer PJ; Jabbal-Gill I; Hinchcliffe M; Illum L; Chatfield S; Roberts M
    Infect Immun; 2000 Oct; 68(10):5764-70. PubMed ID: 10992483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 26. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant.
    Powers DC; Hanscome PJ; Pietrobon PJ
    Vaccine; 1995 Oct; 13(14):1330-5. PubMed ID: 8585289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemagglutinin stem reactive antibody response in individuals immunized with a seasonal influenza trivalent vaccine.
    Zhao X; Qin K; Guo J; Wang D; Li Z; Zhu W; Liu L; Wang D; Shu Y; Zhou J
    Protein Cell; 2015 Jun; 6(6):453-457. PubMed ID: 25940943
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immune response to influenza vaccination among peritoneal dialysis patients].
    Dogliani M; Fidelio T; Scalzo B; Iacono G; Bagatella M; Piro F
    Minerva Urol Nefrol; 1998 Mar; 50(1):97-100. PubMed ID: 9578667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to peak serum antibody response to influenza vaccine in the elderly.
    Gross PA; Russo C; Teplitzky M; Dran S; Cataruozolo P; Munk G
    Clin Diagn Lab Immunol; 1996 May; 3(3):361-2. PubMed ID: 8705685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
    Keitel WA; Couch RB; Cate TR; Hess KR; Baxter B; Quarles JM; Atmar RL; Six HR
    J Clin Microbiol; 1994 Oct; 32(10):2468-73. PubMed ID: 7814484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components.
    Beyer WE; Versluis DJ; Kramer P; Diderich PP; Weimar W; Masurel N
    Vaccine; 1987 Mar; 5(1):43-8. PubMed ID: 3577356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.
    Huang KA; Chang SC; Huang YC; Chiu CH; Lin TY
    Sci Rep; 2017 Jan; 7():40027. PubMed ID: 28098157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
    Keitel WA; Couch RB; Quarles JM; Cate TR; Baxter B; Maassab HF
    J Infect Dis; 1993 Feb; 167(2):305-11. PubMed ID: 8421165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.